Rapport Therapeutics, Inc. (RAPP)

32.24 -0.14 (-0.43%) USD  |  NASDAQ  |  Apr 07, 13:08
More

Rapport Therapeutics EV to Free Cash Flow

EV to Free Cash Flow Chart

View EV to Free Cash Flow for RAPP.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EV to Free Cash Flow Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EV to Free Cash Flow Range, Past 5 Years

View EV to Free Cash Flow Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EV to Free Cash Flow Benchmarks

View EV to Free Cash Flow Benchmarks
Start Trial
EyePoint Plc Upgrade
Praxis Precision Medicines, Inc. Upgrade
Bridgebio Oncology Therapeutics, Inc. Upgrade
Olema Pharmaceuticals, Inc. Upgrade
Arcellx, Inc. Upgrade

EV to Free Cash Flow Related Metrics

EV to CFO Upgrade
EV to Assets (Quarterly) Upgrade
EV to Earnings Upgrade